Trial search - ClinicalTrials.eu

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

A study to evaluate the effectiveness of epcoritamab in patients with Waldenström’s macroglobulinemia that has returned or has not responded to previous treatments.

Recruiting

1 1 1
Investigated drugs:
- Epcoritamab
A Study of Zanubrutinib for Patients with Anti-MAG Antibody Neuropathy Associated with Blood Disorders or Abnormal Protein in the Blood

Recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Zanubrutinib
Study on Venetoclax and Rituximab for Patients with Waldenström’s Macroglobulinemia

Recruiting

2 1 1 1
Investigated diseases:
- Waldenstrom’s macroglobulinaemia
Investigated drugs:
Evaluating Sonrotoclax Alone and Combined with Zanubrutinib for Patients with Previously Untreated or Relapsed/Refractory Waldenström Macroglobulinemia

Not recruiting

2 1 1
Investigated diseases:
- Waldenstrom’s macroglobulinaemia
- Waldenstrom’s macroglobulinaemia refractory
Investigated drugs:
- N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
- Zanubrutinib
Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

Not recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Ibrutinib
+1
Study of CLR 131 for Patients with Relapsed or Refractory Waldenstrom Macroglobulinemia

Not recruiting

2 1 1 1
Investigated drugs:
Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Waldenstrom Macroglobulinemia Using a Drug Combination

Not recruiting

2 1 1 1
Investigated diseases:
- Waldenstrom’s macroglobulinaemia
- Waldenstrom’s macroglobulinaemia refractory
Investigated drugs:
+1
Long-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin’s Lymphoma, Multiple Myeloma, or Acute Leukemia

Not recruiting

3 1 1
Investigated drugs:
- Venetoclax
+1
Study on Carfilzomib and Ibrutinib for Patients with Waldenström’s Macroglobulinemia

Not recruiting

2 1 1 1
Investigated diseases:
- Waldenstrom’s macroglobulinaemia
Investigated drugs:
- Carfilzomib
- Ibrutinib
Study on the Effectiveness of Bortezomib, Rituximab, and Ibrutinib for Patients with Newly Diagnosed Waldenström’s Macroglobulinemia

Not recruiting

2 1 1 1
Investigated diseases:
- Waldenstrom’s macroglobulinaemia
Investigated drugs:

Find clinical trials in your area

Matched clinical trials

We use cookies